Artificial miRNAs Mitigate shRNA-mediated Toxicity in the Brain: Implications for the Therapeutic Development of RNAi

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0801775105
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Plasmid-Based shRNA Lentiviral Particle Production for RNAi Applications

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2014English

Anti-Vegf Antibodies Mitigate the Development of Radiation Necrosis in Mouse Brain

Clinical Cancer Research
Cancer ResearchOncology
2014English

Targeting RNA-mediated Toxicity in C9ORF72 ALS/FTD by RNAi-based Gene Therapy

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2019English

699. shRNA Sense Strand Neutralization Reduces Off-Targeting, Ameliorates Toxicity and Enhances Efficacy of RNAi-Based HBV Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

shRNA and siRNA Delivery to the Brain

Advanced Drug Delivery Reviews
Pharmaceutical Science
2007English

The Function of RNAi in Plant Development

Cold Spring Harbor Symposia on Quantitative Biology
BiochemistryGeneticsMolecular Biology
2006English

Development of Vectors for the Regulated Expression of RNAi

2005English

RNAi Mediated Myosuppressin Deficiency Affects Muscle Development and Survival in the Salmon Louse (Lepeophtheirus Salmonis)

Scientific Reports
Multidisciplinary
2019English

Novel Therapeutic Approach Mediated by Microglia for Rare Brain Diseases

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy